Timing of initiation of antiretroviral therapy in AIDS-free HIV-1-infected patients: a collaborative analysis of 18 HIV cohort studies

This publication has 72 references indexed in Scilit:

• The role of HIV in serious diseases other than AIDS
  AIDS, 2008
• Major Clinical Outcomes in Antiretroviral Therapy (ART)–Naive Participants and in Those Not Receiving ART at Baseline in the SMART Study
  The Journal of Infectious Diseases, 2008
• Importance of Baseline Prognostic Factors With Increasing Time Since Initiation of Highly Active Antiretroviral Therapy
  JAIDS Journal of Acquired Immune Deficiency Syndromes, 2007
• Prognosis of HIV-1-infected patients up to 5 years after initiation of HAART: collaborative analysis of prospective studies
  AIDS, 2007
• Class of Antiretroviral Drugs and the Risk of Myocardial Infarction
  New England Journal of Medicine, 2007
• When should antiretroviral therapy for HIV be started?
  BMJ, 2007
• Determinants of survival following HIV-1 seroconversion after the introduction of HAART
  The Lancet, 2003
• Initiation of Highly Active Antiretroviral Therapy at CD4⁺T Lymphocyte Counts of >350 cells/mm³: Disease Progression, Treatment Durability, and Drug Toxicity
  Clinical Infectious Diseases, 2003
• The Swiss HIV Cohort Study: Rationale, organization and selected baseline characteristics
  International Journal of Public Health, 1994
• THE MULTICENTER AIDS COHORT STUDY: RATIONALE, ORGANIZATION, AND SELECTED CHARACTERISTICS OF THE PARTICIPANTS
  American Journal of Epidemiology, 1987